Page last updated: 2024-08-21

tetramethylpyrazine and Mesenteric Vascular Occlusion

tetramethylpyrazine has been researched along with Mesenteric Vascular Occlusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gál, P; Guzy, J; Pekárová, T; Tomečková, V; Tóth, Š; Varga, J; Veselá, J	1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Mesenteric Vascular Occlusion

Article	Year
Intravenous administration of tetramethylpyrazine reduces intestinal ischemia-reperfusion injury in rats. The American journal of Chinese medicine, 2013, Volume: 41, Issue:4 Topics: Administration, Intravenous; Animals; Apoptosis; Disease Models, Animal; Goblet Cells; Intestinal Mucosa; Jejunum; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Paneth Cells; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Vasodilator Agents	2013

Article

Year

Intravenous administration of tetramethylpyrazine reduces intestinal ischemia-reperfusion injury in rats.

The American journal of Chinese medicine, 2013, Volume: 41, Issue:4

Topics: Administration, Intravenous; Animals; Apoptosis; Disease Models, Animal; Goblet Cells; Intestinal Mucosa; Jejunum; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Paneth Cells; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Vasodilator Agents

2013